GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

ebdarokimab   Click here for help

GtoPdb Ligand ID: 13875

Synonyms: AK-101 | AK101
Approved drug Immunopharmacology Ligand
ebdarokimab is an approved drug
Compound class: Antibody
Comment: Ebdarokimab (AK101) is a humanized IgG1-κ, dual IL-12/IL-23 targeting monoclonal antibody. It binds to the common p40 subunit (IL12B) of these cytokines and disrupts pro-inflammatory signalling via their receptors on T cells and natural killer (NK) cells.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2025)
International Nonproprietary Names Click here for help
INN number INN
11582 ebdarokimab
Synonyms Click here for help
AK-101 | AK101
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1126
Other databases
GtoPdb PubChem SID 513757560
Search PubMed clinical trials ebdarokimab
Search PubMed titles ebdarokimab
Search PubMed titles/abstracts ebdarokimab